Schizoaffective Disorders Completed Phase 4 Trials for Varenicline (DB01273)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00492349Varenicline Adjunctive Treatment in SchizophreniaTreatment
NCT00621777A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar DisorderTreatment